留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

单核细胞糖酵解通路表达与高血压脑出血患者颅内压及临床预后的相关性

裴红莎 徐铭阳 贾宝铭 苏建龙 冯一恭 薛思博 宋志俊

裴红莎, 徐铭阳, 贾宝铭, 苏建龙, 冯一恭, 薛思博, 宋志俊. 单核细胞糖酵解通路表达与高血压脑出血患者颅内压及临床预后的相关性[J]. 昆明医科大学学报, 2025, 46(5): 110-117. doi: 10.12259/j.issn.2095-610X.S20250513
引用本文: 裴红莎, 徐铭阳, 贾宝铭, 苏建龙, 冯一恭, 薛思博, 宋志俊. 单核细胞糖酵解通路表达与高血压脑出血患者颅内压及临床预后的相关性[J]. 昆明医科大学学报, 2025, 46(5): 110-117. doi: 10.12259/j.issn.2095-610X.S20250513
Hongsha PEI, Mingyang XU, Baoming JIA, Jianlong SU, Yigong FENG, Sibo XUE, Zhijun SONG. Correlation between Glycolytic Pathway of Monocytes and Intracranial Pressure and Clinical Prognosis in Patients with Hypertensive Cerebral Hemorrhage[J]. Journal of Kunming Medical University, 2025, 46(5): 110-117. doi: 10.12259/j.issn.2095-610X.S20250513
Citation: Hongsha PEI, Mingyang XU, Baoming JIA, Jianlong SU, Yigong FENG, Sibo XUE, Zhijun SONG. Correlation between Glycolytic Pathway of Monocytes and Intracranial Pressure and Clinical Prognosis in Patients with Hypertensive Cerebral Hemorrhage[J]. Journal of Kunming Medical University, 2025, 46(5): 110-117. doi: 10.12259/j.issn.2095-610X.S20250513

单核细胞糖酵解通路表达与高血压脑出血患者颅内压及临床预后的相关性

doi: 10.12259/j.issn.2095-610X.S20250513
基金项目: 河北省卫生健康委医学科学研究课题(20231466)
详细信息
    作者简介:

    裴红莎(1985~),男,河北邢台人,医学硕士,主治医师,主要从事高血压脑出血诊疗工作

    通讯作者:

    徐铭阳,E-mail:zhibi5512@163.com

  • 中图分类号: R743

Correlation between Glycolytic Pathway of Monocytes and Intracranial Pressure and Clinical Prognosis in Patients with Hypertensive Cerebral Hemorrhage

  • 摘要:   目的  探讨外周血单核细胞(peripheral blood mononuclear cells,PBMCs)糖酵解相关指标[葡萄糖转运蛋白1(glucose transporter 1,GLUT1),果糖-2,6-二磷酸酶3(fructose-2,6-bisphosphatase 3,PFKFB3),乳酸激酶M2(Pyruvate kinase M2,PKM2)]与高血压脑出血(hypertensive intracerebral hemorrhage,HICH)患者颅内压及临床预后的相关性。  方法  回顾性收集2021年1月至2022年6月在邢台市中心医院住院的85例HICH患者作为研究对象。通过酶联免疫吸附测定试剂盒分析PBMCs中PKM2,GLUT1,PFKFB3水平。在HICH发作后6个月,使用改良Rankin量表(modified Rankin scale,mRS)评分来评估短期结局,将患者分为预后良好(mRS评分≤2)和预后不良(mRS得分≥3)。  结果  破入脑室组HICH患者PBMCs中PKM2,PFKFB3和GLUT1水平较非破入脑室组患者进一步降低(P < 0.05)。出院6个月后,非破入脑室组HICH患者中8例(22.9%)患者预后不良,破入脑室组HICH患者中28例(56.0%)患者预后不良,差异具有统计学意义(χ2 = 9.263,P = 0.002)。与预后良好组相比,预后不良组HICH患者PBMCs中PKM2,GLUT1水平降低(P < 0.05)。在破入脑室组HICH患者中,与预后良好组相比,预后不良组HICH患者PBMCs中PKM2,GLUT1水平降低(P < 0.05)。在破入脑室组HICH患者中,PKM2,GLUT1预测HICH患者不良预后的AUC分别为0.879(95%CI 0.807~0.951),0.897(95%CI 0.831~0.963)。  结论  HICH破入脑室患者PBMCs中PKM2,GLUT1水平明显降低,二者表达与患者颅内压呈负相关性,并可用于预测患者的短期预后。
  • 图  1  各组受试者PBMCs中糖酵解相关指标

    A:PBMCs中PKM2的表达;B:PBMCs中PKM2的表达;C:PBMCs中GLUT1的表达;对照组相比**P < 0.01、***P < 0.001、****P < 0.0001。

    Figure  1.  Glycolysis-related indexes in PBMCs of subjects in each group

    图  2  HICH患者PBMCs中糖酵解相关指标水平与颅内压的相关性分析

    A:PBMCs中PKM2与颅内压的相关性;B:PBMCs中PFKFB3与颅内压的相关性;C:PBMCs中GLUT1与颅内压的相关性。

    Figure  2.  Correlation analysis between the levels of glycolysis-related indexes in PBMCs of HICH patients and intracranial pressure.

    图  3  不同预后组HICH患者PBMCs中糖酵解相关指标水平比较

    A:PBMCs中PKM2的表达;B:PBMCs中PKM2的表达;C:PBMCs中GLUT1的表达;与预后良好组比较,**P < 0.01。

    Figure  3.  Comparison of levels of glycolysis-related indexes in PBMCs of patients with HICH in different prognosis groups

    图  4  破入脑室HICH患者中不同预后组PBMCs中糖酵解相关指标水平比较

    A:PBMCs中PKM2的表达;B:PBMCs中PKM2的表达;C:PBMCs中GLUT1的表达;与预后良好组比较,**P < 0.01。

    Figure  4.  Comparison of levels of glycolysis-related indexes in PBMCs of patients with HICH with ventricular rupture in different prognosis groups.

    图  5  PKM2,GLUT1水平预测HICH患者不良预后的能力

    A:PKM2,GLUT1水平预测HICH患者破入脑室良预后的能力;B:PKM2,GLUT1水平预测HICH患者不良预后的能力。

    Figure  5.  The ability of PKM2 and GLUT1 levels to predict poor prognosis in HICH patients

    表  1  非破入脑室组和破入脑室组患者特征[($\bar x \pm s $)/n(%)]

    Table  1.   Characteristics of patients in non-ruptured ventricle group and ruptured ventricle group [($\bar x \pm s $)/n(%)]

    特征 对照组(n=50) 高血压组(n=50) 非破入脑室组(n=35) 破入脑室组(n=50) F/t/χ2 P
    男性 18(36.0) 25(50.0) 12(34.3) 18(36.0) 3.219 0.359
    BMI (kg/m2 24.94 ± 3.31 23.44 ± 3.66 24.40 ± 3.94 25.45 ± 4.08 1.915 0.129
    年龄(岁) 51.86 ± 6.34 52.10 ± 7.94 53.09 ± 14.91 51.20 ± 10.56 0.249 0.862
    ICU住院时间(d) 23.37 ± 18.45 33.64 ± 23.83 2.139 0.035b
    机械通气时间(d) 16.23 ± 15.51 22.96 ± 17.38 1.829 0.071
    糖尿病 1(2.9) 1(2.0) 0.638a
    心血管疾病 5(14.3) 3(6.0) 1.658 0.198
    吸烟 14(40.0) 18(36.0) 0.130 0.883
    饮酒 3(8.6) 4(8.0) 0.009 0.825
    收缩压(mmHg) 118.77 ± 14.86 143.23 ± 17.81* 147.26 ± 21.48* 147.67 ± 20.69* 26.300 <0.001b
    舒张压(mmHg) 75.09 ± 9.31 88.11 ± 10.18* 95.90 ± 12.38* 92.60 ± 11.64* 32.692 <0.001b
    颅内压(mmHg) 16.60 ± 5.42 23.11 ± 7.27 4.681 <0.001b
    GCS评分 7.51 ± 2.52 6.21 ± 2.54 2.362 0.020b
    诊断和治疗的时间间隔 2.022 0.155
    <12 h 20(57.1) 36(72.0)
    ≥12 h~24 h 15(42.9) 14(28.0)
    实验数据
    总胆固醇(mmol/L) 4.25 ± 0.89 4.22 ± 1.02 0.170 0.866
    甘油三酯(mmol/L) 1.16 ± 0.60 1.08 ± 0.42 0.723 0.471
    LDL-C(mmol/L) 2.59 ± 0.71 2.38 ± 0.77 1.250 0.215
    HDL-C(mmol/L) 1.07 ± 0.41 1.23 ± 0.41 1.766 0.081
      a为Fisher精确检验;b为差异有统计学意义;与对照组相比,*P < 0.05。
    下载: 导出CSV

    表  2  多变量回归分析HICH患者不良预后的影响因素

    Table  2.   Multivariate regression analysis of influencing factors of poor prognosis in HICH patients

    指标 B S.E. Wald P OR 95%CI
    下限 上限
    PKM2 −0.153 0.043 12.447 <0.001* 0.858 0.789 0.934
    PFKFB3 0.102 0.057 3.139 0.076 1.107 0.989 1.238
    GLUT1 −0.112 0.030 13.537 <0.001*
    0.894 0.843 0.949
    常量 13.846 3.356 17.024 <0.001*
    1030862.018
      *P < 0.05。
    下载: 导出CSV
  • [1] Seiffge D J,Fandler-Höfler S,Du Y,et al. Intracerebral haemorrhage-mechanisms,diagnosis and prospects for treatment and prevention[J]. Nat Rev Neurol,2024,20(12):708-723. doi: 10.1038/s41582-024-01035-w
    [2] Minhas J S,Moullaali T J,Rinkel G J E,et al. Blood pressure management after intracerebral and subarachnoid hemorrhage: The knowns and known unknowns[J]. Stroke,2022,53(4):1065-1073. doi: 10.1161/STROKEAHA.121.036139
    [3] Lee B C,Tsai H H,Chen Z W,et al. Aldosteronism is associated with more severe cerebral small vessel disease in hypertensive intracerebral hemorrhage[J]. Hypertens Res,2024,47(3):608-617. doi: 10.1038/s41440-023-01458-w
    [4] Chen X,Zhou Y,Wang S,et al. Mechanism of baicalein in brain injury after intracerebral hemorrhage by inhibiting the ROS/NLRP3 inflammasome pathway[J]. Inflammation,2022,45(2):590-602. doi: 10.1007/s10753-021-01569-x
    [5] Xiao L,Wang M,Shi Y,et al. Secondary white matter injury mediated by neuroinflammation after intracerebral hemorrhage and promising therapeutic strategies of targeting the NLRP3 inflammasome[J]. Curr Neuropharmacol,2023,21(3):669-686. doi: 10.2174/1570159X20666220830115018
    [6] Zhang R,Zhang Y,Liu Z,et al. Association between neutrophil-to-albumin ratio and long-term mortality of aneurysmal subarachnoid hemorrhage[J]. BMC Neurol,2023,23(1):374-384. doi: 10.1186/s12883-023-03433-x
    [7] Revilla-González G,Varela L M,Ruiz de Azua-López Z,et al. Changes in adhesion and the expression of adhesion molecules in PBMCs after aneurysmal subarachnoid hemorrhage: Relation to cerebral vasospasm[J]. Transl Stroke Res,2024,15(2):378-387. doi: 10.1007/s12975-023-01136-6
    [8] Ya X,Ma L,Liu C,et al. Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients[J]. Clin Transl Med,2024,14(2):e1572-e1606.
    [9] Zink F,Vogt J,Wachter U,et al. Effects of acute subdural hematoma-induced brain injury on energy metabolism in peripheral blood mononuclear cells[J]. Shock,2021,55(3):407-417. doi: 10.1097/SHK.0000000000001642
    [10] Schellinger P D,Bryan R N,Caplan L R,et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology[J]. Neurology,2010,75(2):177-185. doi: 10.1212/WNL.0b013e3181e7c9dd
    [11] 周永芳,伍国锋,董文涛,等. 急性脑出血患者低血钾发生情况及其与短期预后的关系[J]. 重庆医学,2023,52(7):961-966. doi: 10.3969/j.issn.1671-8348.2023.07.001
    [12] Wang C,Bai J,He Q,et al. Therapy management and outcome of acute hydrocephalus secondary to intraventricular hemorrhage in adults[J]. Chin Neurosurg J,2024,10(1):17-26. doi: 10.1186/s41016-024-00369-0
    [13] 郑海军,戴凯茜,娄晓辉,等. 缺氧诱导因子-1α/血管内皮生长因子通路表达与高血压脑出血破入脑室患者颅内压及预后的相关性[J]. 中华高血压杂志,2022,30(3):283-286.
    [14] Maida C D,Norrito R L,Rizzica S,et al. Molecular pathogenesis of ischemic and hemorrhagic strokes: background and therapeutic approaches[J]. Int J Mol Sci,2024,25(12):6297-6331. doi: 10.3390/ijms25126297
    [15] Johnson C W,Askenase M H,Beatty H E,et al. Single cell rna-sequencing reveals array of immune activation states in intracerebral hemorrhage[J]. Stroke,2022,53(Suppl_1):A99-A99.
    [16] Ya X L,Ma L,Liu C L,et al. Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients[J]. Clin Transl Med,2024,14(2):e1572-e1606. doi: 10.1002/ctm2.1572
    [17] Xiong X Y,Liang Y J,Zhang X X,et al. PKM2 Nuclear Translocation Promotes Glial Cell Activation and Aggravates the Brain Injury of Intracerebral Hemorrhage[J]. J Integr Neurosci,2023,22(6):168-179. doi: 10.31083/j.jin2206168
    [18] Zhang X,Peng L,Kuang S,et al. Lactate accumulation from HIF-1α-mediated PMN-MDSC glycolysis restricts brain injury after acute hypoxia in neonates[J]. J Neuroinflammation,2025,22(1):59-84. doi: 10.1186/s12974-025-03385-8
    [19] Walsh K B,Zhang X,Zhu X,et al. Intracerebral hemorrhage induces monocyte-related gene expression within six hours: Global transcriptional profiling in swine ICH[J]. Metab Brain Dis,2019,34(3):763-774. doi: 10.1007/s11011-019-00399-z
    [20] Goods B A,Askenase M H,Markarian E,et al. Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu[J]. JCI insight,2021,6(6):e145857-e145868. doi: 10.1172/jci.insight.145857
    [21] Giralt-Steinhauer E,Jiménez-Balado J,Fernández-Pérez I,et al. Genetics and epigenetics of spontaneous intracerebral hemorrhage[J]. Int J Mol Sci,2022,23(12):6479-6490. doi: 10.3390/ijms23126479
    [22] Ya X,Liu C,Ma L,et al. Single‐cell atlas of peripheral blood by CyTOF revealed peripheral blood immune cells metabolic alterations and neutrophil changes in intracranial aneurysm rupture[J]. MedComm,2024,5(8):e637-e655. doi: 10.1002/mco2.637
    [23] Xie W,Fang J,Shan Z,et al. Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications[J]. Sci Adv,2022,8(39):eabo4250-eabo4266. doi: 10.1126/sciadv.abo4250
  • [1] 方杰, 光雪峰, 林霄峰, 戴海龙, 左桐曦, 赖碁.  主动脉内球囊反搏在ST段抬高型心肌梗死合并室间隔穿孔的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20250511
    [2] 王左华, 伍荣凤, 张晓燕, 王惠萍.  血清IL-27、CysC、GAPDH抗体与视神经脊髓炎谱系疾病患儿病情程度的关系及对预后的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20250718
    [3] 方园, 吴昆仑, 张仕涛, 冯阳.  血清中血小板自噬相关因子表达参与动脉瘤性蛛网膜下腔出血患者神经功能损伤及预后的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20250514
    [4] 胡廷欢, 王志华, 赵双林, 刘富睿, 陈丽琼, 袁义文, 陈方经, 樊云山, 杨建义.  V形双通道脊柱内镜技术(VBE)用于LDH伴腰椎不稳患者的临床研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240814
    [5] 刘春艳, 常炳庆, 李超, 任欣, 刘小琴.  T淋巴细胞亚群与急性髓系白血病病理特征的关系及预测化疗预后的价值分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240518
    [6] 张瑞婷, 阎斌, 李祖燕, 孙金敏, 姚锦.  诱导化疗时外周血原始细胞清除时间和初诊时白蛋白水平与急性髓系白血病患者基因突变及预后之间的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240817
    [7] 谭博文, 梁云, 陈环, 雷毅, 王昱涵, 田衍.  术前外周血炎性指标联合肿瘤标记物对可切除结肠癌患者的预后价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241213
    [8] 聂琪, 刘莉, 田玥, 毛晓燕, 郭渠莲, 田新.  儿童急性B淋巴细胞白血病ACTH异常临床特征与预后分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241012
    [9] 赵丽珠, 董莹, 邓玥, 杨丽华.  基于单细胞测序技术分析上皮细胞相关基因与卵巢癌患者预后的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240402
    [10] 门欣怡, 赵静, 申永椿, 季辉, 王秀霞.  外周血免疫球蛋白、血沉、同型半胱氨酸与儿童中枢神经系统血管炎病情程度的关系及对预后的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241217
    [11] 陆小华, 袁洪新.  BTLA、CTLA-4基因多态性与肝癌TACE联合靶向治疗疗效及预后相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230927
    [12] 唐杰夫, 杨德兴, 刘圣哲, 王强, 付凯, 王振方, 栾英, 李敏, 刘荣.  奥密克戎变异株老年重症感染者细胞免疫指标对预后的价值研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231214
    [13] 夏文华, 孙翔, 邵建林.  视神经鞘直径指导神经胶质瘤手术患者脱水治疗的可行性研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220620
    [14] 陈红兰, 吴怡, 胡滔, 王玉明.  外周血G6PD活性检测对于感染高危型人乳头瘤病毒宫颈癌患者的诊断预后价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220203
    [15] 赵广平, 刘盼盼, 刘飞, 李炜, 陈永学, 张凯.  高血压脑出血立体定向颅内血肿清除术中不同麻醉方式的血流动力学及应激反应, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220521
    [16] 康旭, 陈若平, 王晓强.  裂隙脑室综合征的诊断治疗新进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210528
    [17] 付琳.  血压控制护理在颅内动脉瘤栓塞术后患者中的护理效果以及对预后的影响, 昆明医科大学学报.
    [18] 刘博虎.  不同包扎方法对标准去骨瓣减压术后患者颅内压的影响, 昆明医科大学学报.
    [19] 刘健刚.  趋化因子受体CXCR4在颅咽管瘤中的表达及其与预后的关系, 昆明医科大学学报.
    [20] 高血压脑出血合并糖尿病的术式选择及围手术期处理, 昆明医科大学学报.
  • 加载中
图(5) / 表(2)
计量
  • 文章访问数:  80
  • HTML全文浏览量:  37
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-02-06
  • 刊出日期:  2025-05-30

目录

    /

    返回文章
    返回